Investigational Medication for Alpha-1 Patients

Trial Objective

Investigational Medication for Alpha-1 PatientsResearchers want to study the safety, tolerability and effectiveness of an investigational medicine for use in people with alpha-1 antitrypsin deficiency (AATD). Those interested in participating must have a PiZZ genotype. Participants may be able to complete some of the study visits at home with a home health nurse.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Anyone between the ages of 18-80 who are confirmed to have a PiZZ genotype.

Age: 18-80    Gender: Any Gender


Estimated Time Commitment

13-18 weeks



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Available

Trial Contact

For more information, contact:

Kris Eliopoulous

Kristina Eliopoulos
303.270.2622

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Vertex Pharmaceuticals, Inc.

Co-Investigators


Request More Information

Complete this form to learn more about this study and see if you qualify.


*
*
*
*